The effects of the nonselective benzodiazepine lorazepam and the α2/α3 subunit‐selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levels

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical pharmacology in drug development

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cpdd.134PMID 27128218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AZD6280, a Novel Partial &ggr;-Aminobutyric Acid A Receptor Modulator, Demonstrates a Pharmacodynamically Selective Effect Profile in Healthy Male Volunteers

  2015cited by this paper
• The central nervous system effects of the partial GABA-Aα2,3 -selective receptor modulator AZD7325 in comparison with lorazepam in healthy males.

  2014cited by this paper
• A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator - an in vitro and in vivo comparison.

  2012cited by this paper
• An Overview of the CNS-Pharmacodynamic Profiles of Nonselective and Selective GABA Agonists

  2012cited by this paper
• Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

  2011influential reference
• Absorption, excretion, and metabolism of a potential GABA-Aα2/3 receptor modulator in rats

  2011cited by this paper
• Development and SAR of functionally selective allosteric modulators of GABAA receptors.

  2011cited by this paper
• Central nervous system effects of haloperidol on THC in healthy male volunteers

  2010cited by this paper
• Neural bases for addictive properties of benzodiazepines

  2010cited by this paper
• Metoclopramide as pharmacological tool to assess vasopressinergic co-activation of the hypothalamus-pituitary-adrenal (HPA) axis: a study in healthy volunteers.

  2010cited by this paper
• The effects of lorazepam on extrastriatal dopamine D(2/3)-receptors-A double-blind randomized placebo-controlled PET study.

  2009cited by this paper
• Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates.

  2005cited by this paper
• The diagnosis and management of benzodiazepine dependence

  2005cited by this paper
• Evidence for a Significant Role of α3-Containing GABAA Receptors in Mediating the Anxiolytic Effects of Benzodiazepines

  2005cited by this paper
• Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.

  2004cited by this paper
• The neuro-endocrine impact of 3-hydroxy-diazepam (temazepam) in women

  2004cited by this paper
• Biomarkers for the effects of benzodiazepines in healthy volunteers.

  2002cited by this paper
• Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABAAReceptor

  2002cited by this paper
• Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor.

  2002cited by this paper
• Subunit composition, distribution and function of GABA(A) receptor subtypes.

  2002cited by this paper
• Trace fear conditioning involves hippocampal α5 GABAA receptors

  2002cited by this paper
• Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors.

  2002cited by this paper
• Dopamine as a prolactin (PRL) inhibitor.

  2001cited by this paper
• Involvement of central GABAergic neurons in basal and diurnal changes of tuberoinfundibular dopaminergic neuronal activity and prolactin secretion.

  2001cited by this paper
• GABA(A) receptor subtypes: dissecting their pharmacological functions.

  2001cited by this paper
• Prolactin: structure, function, and regulation of secretion.

  2000cited by this paper
• Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

  2000cited by this paper
• Mechanism of action of the hypnotic zolpidem in vivo

  2000cited by this paper
• Molecular and neuronal substrate for the selective attenuation of anxiety.

  2000cited by this paper
• Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

  1999cited by this paper
• Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes

  1999cited by this paper
• Effects of bedtime administration of zolpidem on circadian and sleep-related hormonal profiles in normal women.

  1995cited by this paper
• Bretazenil modulates sleep EEG and nocturnal hormone secretion in normal men

  1995cited by this paper
• Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine.

  1994cited by this paper
• Guidelines for the rational use of benzodiazepines. When and what to use.

  1994cited by this paper
• Guidelines for the Rational Use of Benzodiazepines

  1994cited by this paper
• Neuroendocrine and Monoaminergic Responses to Acute Administration of Alprazolam in Normal Subjects

  1990cited by this paper
• The arcuate nucleus: a site for gamma-aminobutyric acid regulation of prolactin secretion.

  1986cited by this paper
• GABA and anterior pituitary function: anatomical data.

  1984cited by this paper
• Prolactin control by the tubero-infundibular GABAergic system: role of anterior pituitary GABA receptors.

  1984cited by this paper
• Gamma-aminobutyric acid is not likely a physiological prolactin-inhibiting factor.

  1984cited by this paper
• Prolactin stimulation by meals is related to protein content.

  1983cited by this paper
• Inhibitory effect of phentolamine on diazepam-induced growth hormone secretion and lack of effect of diazepam on prolactin secretion in man.

  1982cited by this paper
• The effects of the gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects.

  1982cited by this paper
• Mechanisms subserving the stimulatory and inhibitory components of gamma-aminobutyric acid-ergic control of prolactin secretion in the rat.

  1981cited by this paper
• Acute prolactin release triggered by feeding.

  1981cited by this paper
• Effect of bromazepam on growth hormone and prolactin secretion in normal subjects.

  1981cited by this paper
• Effect of glucose of growth hormone, prolactin and thyroid-stimulating hormone response to diazepam in normal subjects.

  1980cited by this paper
• Dual y-Aminobutyric Acid Control of Prolactin Secretion in the Rat*

  1979cited by this paper
• Dual gamma-aminobutyric acid control of prolactin secretion in the rat.

  1979cited by this paper
• Human Prolactin: 24-Hour Pattern with Increased Release doring Sleep

  1972cited by this paper

• A Practical Synthetic Route to Cinnolines: Application to the Design and Synthesis of RSV NNI Inhibitor JNJ-8003 Analogues.

  2025cites this paper
• Sc(OTf)3-Mediated [4 + 2] Annulations of N-Carbonyl Aryldiazenes with Cyclopentadiene to Construct Cinnoline Derivatives: Azo-Povarov Reaction

  2022cites this paper
• “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State

  2021cites this paper
• GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors.

  2021cites this paper
• Exploring threshold-tracking transcranial magnetic stimulation for cortical inhibition as a novel biomarker for γ-aminobutyric acid A α2,3 receptor signalling in humans

  2019cites this paper
• Cinnoline Scaffold—A Molecular Heart of Medicinal Chemistry?

  2019cites this paper
• Functional Measurements of Central Nervous System Drug Effects in Early Human Drug Development

  2019cites this paper
• Subtype selective γ-Aminobutyric Acid Type A Receptor (GABAAR) Modulators Acting at the Benzodiazepine Binding Site: An Update.

  2019cites this paper
• Functional Measurements of Central Nervous System Drug Effects in Early Human Drug Development

  2019cites this paper
• Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety

  2018cites this paper
• Synthesis of C‐14 labeled GABAA α2/α3 selective partial agonists and the investigation of late‐occurring and long‐circulating metabolites of GABAA receptor modulator AZD7325

  2018cites this paper
• Psychotropics and Male Reproduction.

  2017cites this paper
• Hypnotics and Triazolobenzodiazepines - Best Predictors of High-Dose Benzodiazepine Use: Results from the Luxembourg National Health Insurance Registry

  2015cites this paper